Lilly's Zepbound approved by FDA for sleep apnea treatment
2025-01-02WISH-TV
The FDA has approved Lilly's Zepbound, a glp-1 agonist, for the treatment of sleep apnea, which affects 25 million Americans and is often treated with a CPAP machine, but is often declined due to its cumbersome nature. ...undefined
...